InternationalUSRemember you can easily switch between MIP US and MIP International at any time

The best stories from April Fool’s Day

Emma Barraclough, London


Apple to protect a rectangle and EU agrees patent court venue? It must be April 1

A cynic might say that it is difficult to know which is more far-fetched: that members of the European Union have agreed where to site the EU patent court or that they're chosen a tiny would-be independent country called Sealand off the English coast.

Yesterday anti-software patent group FFII claimed an exclusive, revealing that patent judges would be flown in by helicopter for court proceedings and quoting a Munich-based patent attorney.

Georg Friedrich Reichmann apparently told the group...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

David Knight of @Fieldfisher discussing the Big Bus patent licence case (he's on the right) http://t.co/XqcyJBPR6W http://t.co/38Mc7eXLf5

Jul 2 2015 04:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

Mike Lawrence of JTL Systems is demonstrating some of his inventions at @Fieldfisher patent seminar http://t.co/5JIbvqC2Os

Jul 2 2015 02:39 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @EPOorg: The public can now nominate an #inventor for the European Inventor Award 2016! Please spread the word: http://t.co/LRR4qwI4He #…

Jul 2 2015 12:41 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements